A Kiwi invention that improves recovery from potentially life-threatening bowel conditions is a step closer to full commercialisation following a successful Series A round.
The round raised $4 million at its first close on a $18m pre-money valuation and will have its second close at the end of
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
